Wang X, Yuan CX, Xu B, Yu Z. Diabetic foot ulcers: Classification, risk factors and management. World J Diabetes 2022; 13(12): 1049-1065 [PMID: 36578871 DOI: 10.4239/wjd.v13.i12.1049]
Corresponding Author of This Article
Zhi Yu, PhD, Lecturer, Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, No. 138 Xianlin Road, Nanjing 210023, Jiangsu Province, China. yuzhi@njucm.edu.cn
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Pedal blood flow intact: At least one palpable pulse
0
Clinical evidence of reduced pedal flow
1
Neuropathy
Protective sensation intact
0
Protective sensation lost
1
Bacterial infection
None
0
Present
1
Area
Ulcer < 1 cm2
0
Ulcer ≥ 1 cm2
1
Depth
Ulcer confined to skin and subcutaneous tissue
0
Ulcer reaching muscle, tendon or deeper
1
Total possible score
6
Table 5 Wound, Ischemia, and foot Infection system
Grade
Wound
Ischemia
Foot infection system
Clinical features
ABI (mmHg)
ASP (mmHg)
Toe pressure, TcPO2 (mmHg)
Clinical manifestations
0
No ulcer no gangrene
≥ 0.80
> 100
≥ 60
No symptoms or signs of infection. Infection present, as defined by the presence of at least two of the following items: (1) Local swelling or induration; (2) Erythema 0.5 cm-2 cm around the ulcer; (3) Local tenderness or pain; (4) Local warmth; and (5) Purulent discharge (thick, opaque to white, or sanguineous secretion)
1
Small, shallow ulcer(s) on the distal leg or foot; no exposed bone, unless limited to the distal phalanx
0.6-0.79
70-100
40-59
Local infection involving only the skin and the subcutaneous tissue exclude other causes of an inflammatory response of the skin (e.g., trauma, gout, acute Charcot neuro-osteoarthropathy, fracture, thrombosis, and venous stasis)
2
Deeper ulcer with exposed bone, joint, or tendon generally not involving the heel; shallow heel ulcer without calcaneal involvement, gangrenous changes limited to digits
0.4-0.59
50-70
30-39
Local infection with erythema > 2 cm, or involving structures deeper than skin and subcutaneous tissues (e.g., abscess, osteomyelitis, septic arthritis, and fasciitis), and no systemic inflammatory response signs
3
Extensive, deep ulcers involving forefoot and/or midfoot; deep, full-thickness heel ulcers with or without calcaneal involvement, extensive gangrene involving the forefoot and/or midfoot; full-thickness heel necrosis with calcaneal involvement
≥ 0.39
< 50
< 30
Local infection with signs of SIRS, as manifested by two or more of the following: (1) Temperature > 38 °C or < 36 °C; (2) Heart rate > 90 beats/min; (3) Respiratory rate > 20 breaths/min or PaCO2 < 32 mmHg; and (4) White blood cell count > 12000 or < 4000 cu/mm or 10% immature bands
Citation: Wang X, Yuan CX, Xu B, Yu Z. Diabetic foot ulcers: Classification, risk factors and management. World J Diabetes 2022; 13(12): 1049-1065